abstract |
The present invention relates to tablets containing a high drug content 1- (β-D-glucopyranosyl) -3- (phenylthienylmethyl) benzene compound, in particular within 30 to 95% by weight of the tablet and the pharmaceutical And tablets containing acceptable additives. |